Tuberculous myelitis: a prospective follow-up study.

Mohd Imran KhanRavindra Kumar GargImran RizviHardeep Singh MalhotraNeeraj KumarAmita JainRajesh VermaPraveen Kumar SharmaShweta PandeyRavi UniyalParul Jain

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)

Tuberculous myelitis was seen in approximately 35% of all myelitis cases, in a high tuberculosis endemic zone. Headache, markedly elevated CSF protein and spinal meningeal enhancement were distinguishing features. Tuberculous myelitis patients responded well to corticosteroids.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
spinal cord
prognostic factors
emergency department
patient reported outcomes
hiv aids
hepatitis c virus
cerebrospinal fluid
antiretroviral therapy